Table 1 Sequence analysis of V gene rearrangements amplified from DLBCL and HRS cells of a composite lymphoma

From: Indications for peripheral light-chain revision and somatic hypermutation without a functional B-cell receptor in precursors of a composite diffuse large B-cell and Hodgkin's lymphoma

Cells

Cells positive in PCR

PCR products amplified repeatedly

Original rearrangement potentially functional

Mutation frequency (%)

Functionality after somatic hypermutation

Ongoing mutation

DLBCL

      

CD20+ (2–4 cells/tube)

VHL: 14/20

14 × VH3–23a

+

27–28b

No

 

VHFRIc: 0/20

     
 

Vκ: 10/20

10 × Vκ1D–39

+

18

+

No

 

Vλ: 1/20d

     
 

DH: 7/10

7 × unrearranged

    
 

KDE: 18/20

18 × unrearrangede

    

Negative controlsf

VHL, KDE, DH: 0/4

     
 

VHL, KDE: 0/4

     
 

VHFRI, Vκ, Vλ: 0/8

     

CD20+ (1 cell/tube)

VHL: 18/42

18 × VH3–23

+

27–28b

No

Negative controlsf

VHL: 0/18

     

HL

      

CD30+ (1 cell/tube)

VHL: 8/16

8 × VH3–23

+

7

+

No

 

VHFRI: 14/20

14 × VH3–23

+

7

+

No

 

Vκ: 15/20g

6 × Vκ1D–39h

+

7

+

No

  

14 × Vκ1D–6

+

8

+

No

 

Vλ: 1/20d

     
 

DH: 4/10

4 × unrearranged

    
 

KDE: 13/16

10 × unrearranged

    
  

11 × Jκ−Cκ intron–RSS/KDE rearrangement

    

Negative controlsf

VHL, KDE, DH: 0/4

     
 

VHL, KDE: 0/2

     
 

VHFRI, Vκ, Vλ: 2/8i

     
  1. All sequences were deposited in the EMBL database under accession nos. AJ586890–896.
  2. aFrom two tubes in addition to the clonal rearrangement, unrelated unique rearrangements (VH2–26 and VH4–34) were amplified, likely due to the occasional micromanipulation of nontumor B cells from the DLBCL region.
  3. bIncluding one 1-bp insertion and three deletions (two 1-bp deletions and one larger deletion of 56 bp).
  4. cVHFRI PCR was negative in DLBCL cells due to a large deletion encompassing the primer binding site in FRI.
  5. dOne Vλ1 PCR product out of 20 HRS cells and one Vλ3 PCR product out of 20 DLBCL cells were amplified but not sequenced. These amplificates likely represent cellular contamination, or picking of a bystander B cell in case of the analysis of CD20+ B cells.
  6. eOne single Jκ–Cκ intron–RSS/KDE rearrangement was amplified from a tube from which also a unique VH rearrangement was amplified (see footnote a) and is thus likely derived from a nontumor B cell.
  7. fFor each 10 cells four aliquots of buffer covering the sections during micromanipulation were used as negative controls.
  8. gFrom two tubes in addition to the clonal rearrangement, unrelated unique rearrangements (Vκ1D–33 and Vκ1D–39) were amplified.
  9. hFive of six cells have both one Vκ1D–39 and one Vκ1D–6 rearrangement.
  10. iVκ1D–33 and Vκ1–8 rearrangements not related to the tumor clone.